This story is from January 4, 2022

Natco acquires Dash Pharma for $18 million

Natco acquires Dash Pharma for $18 million
Hyderabad: City-based pharma major Natco Pharma has said that its wholly owned US subsidiary Natco Pharma Inc USA, has completed the acquisition of New Jersey-based Dash Pharmaceuticals LLC for US$18 million.
With this, Dash Pharma will become a 100% wholly owned subsidiary of Natco Pharma Inc and a step-down subsidiary of Natco Pharma, Natco Pharma said in a regulatory filing over the weekend.

Dash Pharma is a front-end pharmaceutical sales, marketing and distribution entity in the US that is expected to have net sales of approximately US$15 million for the financial year ending December 2021.
The Hyderabad-based company said the latest acquisition will provide it with a platform to engage with its customers directly in the US, which is the largest pharmaceutical market in the world.
End of Article
FOLLOW US ON SOCIAL MEDIA